BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2219957)

  • 21. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for determination of carbamazepine concentration in blood of poisoned patients.
    Wilimowska J; Gomółlka E; Pasich A; Jenner B; Szpak D
    Przegl Lek; 2005; 62(6):595-8. PubMed ID: 16225132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of fluorescence polarization immunoassay and high-performance liquid chromatography methods for assay of teicoplanin: can correlation be improved?
    Davani S; Bérard M; Royer B; Kantelip JP; Muret P
    Pathol Biol (Paris); 2004 Dec; 52(10):584-8. PubMed ID: 15596307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography.
    Zighetti ML; Chantarangkul V; Tripodi A; Mannucci PM; Cattaneo M
    Haematologica; 2002 Jan; 87(1):89-94. PubMed ID: 11801469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of detecting methods of digoxin blood drug level].
    Li YX; Mao JY; Li HF
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):285-8, 326. PubMed ID: 17455457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration.
    Dasgupta A; Biddle DA; Wells A; Datta P
    Am J Clin Pathol; 2000 Aug; 114(2):174-9. PubMed ID: 10941331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference between eplerenone and digoxin in fluorescence polarization immunoassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay.
    Yamada T; Suzuki K; Iguchi K; Kanada Y; Kato R; Ijiri Y; Nishihara M; Murakami S; Hayashi T; Tamai H; Tanaka K
    Ther Drug Monit; 2010 Dec; 32(6):774-7. PubMed ID: 20625353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False-positive digoxin measurements due to conjugated metabolite accumulation in combined renal and hepatic dysfunction.
    Vlasses PH; Besarab A; Lottes SR; Conner DP; Green PJ; Gault MH
    Am J Nephrol; 1987; 7(5):355-9. PubMed ID: 3324762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of protein concentration on the determination of digoxin in serum by fluorescence polarization immunoassay.
    Porter WH; Haver VM; Bush BA
    Clin Chem; 1984 Nov; 30(11):1826-9. PubMed ID: 6207958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
    Dasgupta A; Trejo O
    Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx and dry chemistry enzyme immunoassay on the Vitros 950.
    Solnica B
    Clin Chem Lab Med; 2004; 42(8):958-64. PubMed ID: 15387450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment.
    Cobo A; Martín-Suarez A; Calvo MV; Domínguez-Gil A; de Gatta MM
    Ther Drug Monit; 2010 Apr; 32(2):169-76. PubMed ID: 20216123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticle enzyme immunoassay: elimination of interference by monitoring free digoxin concentration.
    Dasgupta A; Scott J
    Am J Clin Pathol; 1998 Jul; 110(1):78-82. PubMed ID: 9661925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of fluorescence polarization immunoassay and HPLC for the determination of theophylline in serum.
    el-Sayed YM; Islam SI
    J Clin Pharm Ther; 1989 Apr; 14(2):127-34. PubMed ID: 2722976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercomparison of seven radioimmunoassay kits and a fluorescence polarization immunoassay kit for digoxin.
    Erickson KA; Green PJ
    Clin Chem; 1984 Jul; 30(7):1225-7. PubMed ID: 6733904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined liquid chromatography/radioimmunoassay with improved specificity for serum digoxin.
    Gault MH; Longerich L; Dawe M; Vasdev SC
    Clin Chem; 1985 Aug; 31(8):1272-7. PubMed ID: 4017230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
    Spinler SA; Al-Jazairi AS; Cheng JW; Kapoor S; Kobrin S; Shaw L
    Ther Drug Monit; 2000 Dec; 22(6):729-36. PubMed ID: 11128242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods.
    Hu MW; Anne L; Forni T; Gottwald K
    Ther Drug Monit; 1990 Nov; 12(6):562-9. PubMed ID: 2275003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.